Doctor's Best Appoints Nate Challen as President [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Dec. 11, 2025 /PRNewswire/ -- Doctor's Best Inc. , a leading nutritional supplement company, has announced the appointment of Nate Challen as president. With nearly two decades of leadership experience in the health and beauty sector, Challen is well-positioned to drive the company's growth initiatives in the nutraceuticals space. Challen is an accomplished business builder with a proven track record of scaling consumer health and beauty brands across North America and global markets, delivering double-digit growth through digital innovation, operational efficiency, and portfolio optimization. He brings deep expertise in developing and executing strategic growth initiatives, expanding market share, and leading diverse, high-performing teams. Challen spent more than a decade at Sanofi Consumer Health, where he held leadership roles across North America and Europe, including serving as General Manager in Canada and Head of Commercial Transformation globally. Prior to Sanofi, Challen
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi's Qfitlia and Cablivi approved in China, expanding care for rare diseases [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesGlobeNewswire
- Why Wall Street Analysts Are Closely Watching Sanofi (SNY) [Yahoo! Finance]Yahoo! Finance
- InduPro Therapeutics Announces Strategic Investment from Sanofi and a Research Collaboration to Advance a Novel Bispecific for Autoimmune Disorders [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 12/12/25 - Form 6-K
- 12/3/25 - Form 6-K
- 11/18/25 - Form 6-K
- SNY's page on the SEC website